Top Pharmaceuticals stocks in Australia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$135.71bn | 35.05 | 1.38% |
NEUNeuren Pharmaceuticals | AU$3.05bn | 19.39 | n/a |
SIGSigma Healthcare | AU$1.94bn | 291.27 | 0.8% |
CUVClinuvel Pharmaceuticals | AU$780.48m | 25.83 | 0.32% |
BOTBotanix Pharmaceuticals | AU$464.14m | n/a | n/a |
MYXMayne Pharma | AU$419.23m | n/a | n/a |
PBPProbiotec | AU$240.72m | 26.48 | 2.36% |
VLSVita Life Sciences | AU$135.36m | 14.47 | 3.75% |
RCERecce Pharmaceuticals | AU$116.11m | n/a | n/a |
NXSNext Science | AU$78.76m | n/a | n/a |
PAAPharmaust | AU$69.20m | n/a | n/a |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
BIOBiome Australia | AU$63.60m | n/a | n/a |
VITVitura Health | AU$50.68m | 5.34 | 11.36% |
SPLStarpharma Holdings | AU$47.36m | n/a | n/a |
LGPLittle Green Pharma | AU$37.51m | n/a | n/a |
MVPMedical Developments International | AU$34.09m | n/a | n/a |
IMCImmuron | AU$20.96m | n/a | n/a |
ACRAcrux | AU$19.69m | n/a | n/a |
OSLOncosil Medical | AU$17.07m | n/a | n/a |